[Pathophysiology of neuronal injury in bacterial meningitis: concepts and implications].
Nau
R
R
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D020169:Caspases / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D007511:Ischemia / Q000503:physiopathology; D007962:Leukocytes / Q000276:immunology / Q000378:metabolism; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology*; D009474:Neurons / Q000378:metabolism* / Q000382:microbiology; D017382:Reactive Oxygen Species / Q000378:metabolism
D000900:Anti-Bacterial Agents; D017382:Reactive Oxygen Species; D018698:Glutamic Acid; D020169:Caspases